Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use
ConclusionWe have demonstrated that NTSR1 is a promising molecular marker for prostate cancer based on patient tissue staining. The NTSR targeted probe18F-DEG-VS-NT demonstrated high tumor to background contrast in animal models, which could be valuable in selecting patients for therapies targeting NTSR1 as well as monitoring therapeutic efficacy during treatment accordingly.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Androgen Independent Prostate Cancer | Benign Prostatic Hyperplasia | Brain | Cancer | Cancer & Oncology | Neurology | Nuclear Medicine | Prostate Cancer | Study